MyFinsight
Home
Blog
About
Net income (loss)
$164,494K
(348.19%↑ Y/Y)
Stock-based compensation
expense
$86,625K
(-22.43%↓ Y/Y)
Non-cash interest
expense on liabilities...
$79,043K
(116.72%↑ Y/Y)
Proceeds from exercise of
stock options and...
$33,561K
(-58.68%↓ Y/Y)
Proceeds from
liabilities related to the...
$6,000K
Accounts payable,
accrued expenses and...
$61,617K
(-66.17%↓ Y/Y)
Depreciation and
amortization
$13,899K
(-0.32%↓ Y/Y)
Other
$8,278K
(144.72%↑ Y/Y)
Deferred income taxes
$2,657K
(-72.71%↓ Y/Y)
Deferred revenue
$802K
(106.13%↑ Y/Y)
Inventory
-$280K
(97.49%↑ Y/Y)
Net cash provided by
operating activities
$326,724K
(112.53%↑ Y/Y)
Net cash provided by
financing activities
$36,237K
(-32.59%↓ Y/Y)
Canceled cashflow
$90,971K
Canceled cashflow
$3,324K
Net increase in
cash, cash...
-$2,941K
(-103.14%↓ Y/Y)
Canceled cashflow
$362,961K
Sales and maturities
of marketable...
$272,795K
(-17.95%↓ Y/Y)
Proceeds from maturity of
restricted and other...
$17,900K
(93.51%↑ Y/Y)
Prepaid expenses and
other assets
$59,369K
(976.04%↑ Y/Y)
Accounts receivable, net
$31,602K
(-76.92%↓ Y/Y)
Repayment of liabilities
related to the sale of...
$3,318K
Other financing
activities
-$6K
Net cash used in
investing activities
-$363,457K
(-157.08%↓ Y/Y)
Canceled cashflow
$290,695K
Effect of exchange rate
changes on cash, cash...
-$2,445K
(-108.89%↓ Y/Y)
Purchases of marketable
securities
$575,672K
(25.27%↑ Y/Y)
Purchases of property,
plant and equipment
$34,680K
(142.64%↑ Y/Y)
Other investing
activities
$25,900K
Purchases of restricted
and other...
$17,900K
(93.51%↑ Y/Y)
Back
Back
Cash Flow
logo (21)-svg-svg
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
logo (21)-svg-svg
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
source: myfinsight.com